MergerAug 12, 2026, 04:38 PM
ASPAC III Acquisition Corp. Q2 Loss; Nasdaq Compliance Tied to Merger
AI Summary
ASPAC III Acquisition Corp. reported a net loss of $(15,218) for Q2 2026 and $(129,206) for the six months ended June 30, 2026. The company received a Nasdaq delisting notice due to stockholders' equity falling below the $2.5 million minimum, with a compliance plan accepted that relies on the proposed merger with Bioserica International Limited. The business combination deadline has been extended to November 12, 2026, and the company faces substantial doubt about its ability to continue as a going concern if the merger is not completed.
Key Highlights
- Net loss of $(15,218) for Q2 2026, compared to $379,939 income in Q2 2025.
- Net loss of $(129,206) for H1 2026, compared to $793,141 income in H1 2025.
- Cash decreased to $633,724 as of June 30, 2026, from $871,350 at December 31, 2025.
- Stockholders' equity was $237,744, below Nasdaq's $2.5 million minimum requirement.
- Nasdaq accepted compliance plan, granting extension until November 12, 2026.
- Proposed merger with Bioserica International Limited values the target at $217.86 million.
- Business combination deadline extended to November 12, 2026, following shareholder approval.
- Sponsor exchanged 1,499,900 Class B ordinary shares for Class A ordinary shares.
Price Impact
More from ASPC